{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:23:53Z","timestamp":1787009033024,"version":"build-2736575974"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030679","name":"MundiPharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030679","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We sought to evaluate the comparative activity of rezafungin compared with caspofungin and other antifungal classes against biofilms from a large clinical panel of Candida strains (n\u200a=\u200a167).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Biofilm killing and inhibition were assessed using standard XTT [2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide salt] metabolic assessment. Biofilm time\u2013kill kinetics were also evaluated using metabolic and viable cell counts. Microscopy was performed to visually assess biofilm inhibition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Rezafungin was shown to outperform caspofungin and other antifungals against C. albicans, C. parapsilosis, C. tropicalis and Nakaseomyces glabratus (previously called C. glabrata) strains with a heterogeneous biofilm phenotype. Assessment of high biofilm-forming strains at 0.03\u2005mg\/L concentrations showed that rezafungin killed biofilms to an equal or greater extent than caspofungin. Time\u2013kill studies showed a rapid reduction in metabolism and viable cfus by both rezafungin and caspofungin, but with little difference between both compounds. Evaluation of biofilm inhibition characteristics of both compounds showed that rezafungin was marginally more effective than caspofungin, which was corroborated by microscopical analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Together, these data show that rezafungin is non-inferior to caspofungin in terms of anti-biofilm activity and displays characteristics that suggest it can control biofilms more effectively than caspofungin. Further evaluation is required to establish whether these in vitro effects translate clinically, but the data indicate an opportunity for rezafungin to be used for the clinical management of biofilm-related diseases.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkag058","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T12:43:24Z","timestamp":1770209004000},"source":"Crossref","is-referenced-by-count":2,"title":["Rezafungin exhibits anti-biofilm properties against fungal biofilms\n                    <i>in vitro<\/i>"],"prefix":"10.1093","volume":"81","author":[{"given":"Hafsa","family":"Abduljalil","sequence":"first","affiliation":[{"name":"Safeguarding Health Through Infection Prevention (SHIP) Research Group, Research Centre for Health, School of Health and Life Sciences, Glasgow Caledonian University , 70 Cowcaddens Road, Glasgow G4 0BA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3037-5295","authenticated-orcid":false,"given":"Kerry","family":"Bartie","sequence":"additional","affiliation":[{"name":"Safeguarding Health Through Infection Prevention (SHIP) Research Group, Research Centre for Health, School of Health and Life Sciences, Glasgow Caledonian University , 70 Cowcaddens Road, Glasgow G4 0BA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5474-4783","authenticated-orcid":false,"given":"Abhijit M","family":"Bal","sequence":"additional","affiliation":[{"name":"Microbiology Department, Glasgow Royal Infirmary , Glasgow G4 0SF ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1071-6040","authenticated-orcid":false,"given":"Riina","family":"Rautemaa-Richardson","sequence":"additional","affiliation":[{"name":"Mycology Reference Centre Manchester, ECMM Centre of Excellence, and Department of Infectious Diseases, Wythenshawe Hospital, Manchester University NHS Foundation Trust , ; , Manchester ,","place":["UK UK"]},{"name":"and Manchester Biomedical Research Centre, Division of Evolution, Infection and Genomics, Faculty of Biology, Medicine and Health, University of Manchester , ; , Manchester ,","place":["UK UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5002-6215","authenticated-orcid":false,"given":"Craig","family":"Williams","sequence":"additional","affiliation":[{"name":"Microbiology Department, Lancaster Royal Infirmary , Lancaster ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6636-4278","authenticated-orcid":false,"given":"Ryan","family":"Kean","sequence":"additional","affiliation":[{"name":"Safeguarding Health Through Infection Prevention (SHIP) Research Group, Research Centre for Health, School of Health and Life Sciences, Glasgow Caledonian University , 70 Cowcaddens Road, Glasgow G4 0BA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0932-3514","authenticated-orcid":false,"given":"Gordon","family":"Ramage","sequence":"additional","affiliation":[{"name":"Safeguarding Health Through Infection Prevention (SHIP) Research Group, Research Centre for Health, School of Health and Life Sciences, Glasgow Caledonian University , 70 Cowcaddens Road, Glasgow G4 0BA ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"2026030422163085700_dkag058-B1","doi-asserted-by":"publisher","first-page":"001407","DOI":"10.1099\/mic.0.001407","article-title":"Microbial primer: in vivo biofilm","volume":"169","author":"Rumbaugh","year":"2023","journal-title":"Microbiology (Reading)"},{"key":"2026030422163085700_dkag058-B2","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41579-025-01147-0","article-title":"Fungal biofilms in human health and disease","volume":"23","author":"Ramage","year":"2025","journal-title":"Nat Rev Microbiol"},{"key":"2026030422163085700_dkag058-B3","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1128\/JCM.00131-07","article-title":"Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia","volume":"45","author":"Tumbarello","year":"2007","journal-title":"J Clin Microbiol"},{"key":"2026030422163085700_dkag058-B4","doi-asserted-by":"publisher","first-page":"e33705","DOI":"10.1371\/journal.pone.0033705","article-title":"Risk factors and outcomes of candidemia caused by biofilm-forming isolates in a tertiary care hospital","volume":"7","author":"Tumbarello","year":"2012","journal-title":"PLoS One"},{"key":"2026030422163085700_dkag058-B5","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jinf.2023.08.001","article-title":"European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: results from the ECMM Candida III study","volume":"87","author":"Arendrup","year":"2023","journal-title":"J Infect"},{"key":"2026030422163085700_dkag058-B6","doi-asserted-by":"publisher","first-page":"915","DOI":"10.3389\/fmicb.2016.00915","article-title":"A prospective surveillance study of candidaemia: epidemiology, risk factors, antifungal treatment and outcome in hospitalized patients","volume":"7","author":"Rajendran","year":"2016","journal-title":"Front Microbiol"},{"key":"2026030422163085700_dkag058-B7","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cmi.2015.09.018","article-title":"Biofilm formation is a risk factor for mortality in patients with Candida albicans bloodstream infection\u2014Scotland, 2012\u20132013","volume":"22","author":"Rajendran","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2026030422163085700_dkag058-B8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/jof4010012","article-title":"Gaining insights from Candida biofilm heterogeneity: one size does not fit all","volume":"4","author":"Kean","year":"2018","journal-title":"J Fungi (Basel)"},{"key":"2026030422163085700_dkag058-B9","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2026030422163085700_dkag058-B10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1093\/jac\/dkf045","article-title":"Echinocandins: a new class of antifungal","volume":"49","author":"Denning","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"2026030422163085700_dkag058-B11","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1128\/AAC.46.6.1773-1780.2002","article-title":"Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins","volume":"46","author":"Kuhn","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2026030422163085700_dkag058-B12","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1128\/AAC.46.11.3591-3596.2002","article-title":"In vitro activity of caspofungin against Candida albicans biofilms","volume":"46","author":"Bachmann","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"2026030422163085700_dkag058-B13","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1128\/JCM.40.6.2228-2230.2002","article-title":"In vitro activity of caspofungin (MK-0991) against Candida albicans clinical isolates displaying different mechanisms of azole resistance","volume":"40","author":"Bachmann","year":"2002","journal-title":"J Clin Microbiol"},{"key":"2026030422163085700_dkag058-B14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1469-0691.2008.02660.x","article-title":"Differential in vitro activity of anidulafungin, caspofungin and micafungin against Candida parapsilosis isolates recovered from a burn unit","volume":"15","author":"Ghannoum","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"2026030422163085700_dkag058-B15","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1128\/AAC.00211-08","article-title":"In vitro activity of anidulafungin against Candida albicans biofilms","volume":"52","author":"Jacobson","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"2026030422163085700_dkag058-B16","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1128\/AAC.01724-08","article-title":"In vitro activity of micafungin against planktonic and sessile Candida albicans isolates","volume":"53","author":"Jacobson","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2026030422163085700_dkag058-B17","doi-asserted-by":"publisher","first-page":"e0016125","DOI":"10.1128\/msphere.00161-25","article-title":"Tolerance and heteroresistance to echinocandins in Candida auris: conceptual issues, clinical implications, and outstanding questions","volume":"10","author":"Shor","year":"2025","journal-title":"mSphere"},{"key":"2026030422163085700_dkag058-B18","doi-asserted-by":"publisher","first-page":"e0158423","DOI":"10.1128\/aac.01584-23","article-title":"Outcomes by Candida spp. in the ReSTORE Phase 3 trial of rezafungin versus caspofungin for candidemia and\/or invasive candidiasis","volume":"68","author":"Locke","year":"2024","journal-title":"Antimicrob Agents Chemother"},{"key":"2026030422163085700_dkag058-B19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S1473-3099(23)00551-0","article-title":"Efficacy and safety of rezafungin and caspofungin in candidaemia and invasive candidiasis: pooled data from two prospective randomised controlled trials","volume":"24","author":"Thompson","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026030422163085700_dkag058-B20","doi-asserted-by":"publisher","first-page":"e01750-17","DOI":"10.1128\/AAC.01750-17","article-title":"Cd101, a novel echinocandin, possesses potent antibiofilm activity against early and mature Candida albicans biofilms","volume":"62","author":"Chandra","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2026030422163085700_dkag058-B21","doi-asserted-by":"publisher","first-page":"e0013725","DOI":"10.1128\/aac.00137-25","article-title":"Antibiofilm activity of manogepix, ibrexafungerp, amphotericin B, rezafungin, and caspofungin against Candida spp. biofilms of reference and clinical strains","volume":"69","author":"Ceballos-Garzon","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"2026030422163085700_dkag058-B22","doi-asserted-by":"publisher","first-page":"e01992-20","DOI":"10.1128\/AAC.01992-20","article-title":"Efficacy of rezafungin in prophylactic mouse models of invasive candidiasis, aspergillosis, and Pneumocystis pneumonia","volume":"65","author":"Miesel","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"2026030422163085700_dkag058-B23","doi-asserted-by":"publisher","first-page":"100112","DOI":"10.1016\/j.bioflm.2023.100112","article-title":"An integrated transcriptomic and metabolomic approach to investigate the heterogeneous Candida albicans biofilm phenotype","volume":"5","author":"Delaney","year":"2023","journal-title":"Biofilm"},{"key":"2026030422163085700_dkag058-B24","doi-asserted-by":"publisher","first-page":"iyac031","DOI":"10.1093\/genetics\/iyac031","article-title":"Population genetics and microevolution of clinical Candida glabrata reveals recombinant sequence types and hyper-variation within mitochondrial genomes, virulence genes, and drug targets","volume":"221","author":"Helmstetter","year":"2022","journal-title":"Genetics"},{"key":"2026030422163085700_dkag058-B25","author":"CLSI"},{"key":"2026030422163085700_dkag058-B26","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1038\/nprot.2008.141","article-title":"A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and its application to antifungal susceptibility testing","volume":"3","author":"Pierce","year":"2008","journal-title":"Nat Protoc"},{"key":"2026030422163085700_dkag058-B27","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1128\/AAC.45.9.2475-2479.2001","article-title":"Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms","volume":"45","author":"Ramage","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2026030422163085700_dkag058-B28","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1128\/JCM.44.3.760-763.2006","article-title":"In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2026030422163085700_dkag058-B29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/1471-2180-14-182","article-title":"Biofilms formed by Candida albicans bloodstream isolates display phenotypic and transcriptional heterogeneity that are associated with resistance and pathogenicity","volume":"14","author":"Sherry","year":"2014","journal-title":"BMC Microbiol"},{"key":"2026030422163085700_dkag058-B30","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.jinf.2022.09.028","article-title":"Aneuploidy underlies paradoxical growth of rezafungin and enables cross-tolerance to echinocandins in Candida albicans","volume":"85","author":"Li","year":"2022","journal-title":"J Infect"},{"key":"2026030422163085700_dkag058-B31","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1099\/jmm.0.000237","article-title":"Comparing apples and oranges: considerations for quantifying candidal biofilms with XTT [2,3-bis(2-methoxy-4-nitro-5-sulfo-phenyl)-2H-tetrazolium-5-carboxanilide] and the need for standardized testing","volume":"65","author":"Ramage","year":"2016","journal-title":"J Med Microbiol"},{"key":"2026030422163085700_dkag058-B32","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1080\/17460913.2025.2604475","article-title":"Real-world experience with rezafungin for the treatment of biofilm-forming Candida infections","volume":"20","author":"Albanell-Fernandez","year":"2025","journal-title":"Future Microbiol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/4\/dkag058\/67229798\/dkag058.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/4\/dkag058\/67229798\/dkag058.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T03:16:40Z","timestamp":1772680600000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag058\/8505992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,3,4]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag058","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2026,3,4]]},"article-number":"dkag058"}}